Good morning :)
Switch to
Place Order

Venus Remedies Ltd

VENUSREM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹417 cr, stock is ranked 1,185
High RiskStock is 3.18x as volatile as Nifty
312.355.15 (-1.62%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹417 cr, stock is ranked 1,185
High RiskStock is 3.18x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
6.76
PB RatioPB Ratio
1.26
Dividend YieldDiv. Yield
Sector PESector PE
38.99
Sector PBSector PB
5.88
Sector Div YldSctr Div Yld
0.64%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Venus Remedies Limited is engaged in pharmaceutical product manufacturing business. The Company provides formulations and manufactures dosage injectables.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021374.66327.98357.29591.20-30.70-28.58-8.2361.76
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transactions 
Announced OnJun 8, 2021

Venus Remedies Limited has informed the Exchange about related Party Transactions Pursuant to regulation 23(9) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015, Kindly find enclosed herewith a disclosure on related party transaction on Standalone and Consolidated basis for the year ended on 31st March 2021. | Download

Venus Remedies Limited has informed the Exchange about related Party Transactions Pursuant to regulation 23(9) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015, Kindly find enclosed herewith a disclosure on related party transaction on Standalone and Consolidated basis for the year ended on 31st March 2021. | Download

Copy of Newspaper Publication 
Announced OnJun 2, 2021

Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication of financial r esults | Download

Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication of financial r esults | Download

Cash Dividend 
Ex. DateSep 23, 2013

Final • Div/Share: ₹ 3

See all events